| Immunology of multiple sclerosis M Sospedra, R Martin Annu. Rev. Immunol. 23, 683-747, 2005 | 2810 | 2005 |
| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011 | 2804 | 2011 |
| Immunological aspects of demyelinating diseases R Martin, HF McFarland, DE McFarlin Annual review of immunology 10 (1), 153-187, 1992 | 1315 | 1992 |
| Multiple sclerosis: a complicated picture of autoimmunity HF McFarland, R Martin Nature immunology 8 (9), 913-919, 2007 | 1269 | 2007 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1230 | 2013 |
| Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand B Bielekova, B Goodwin, N Richert, I Cortese, T Kondo, G Afshar, B Gran, ... Nature medicine 6 (10), 1167-1175, 2000 | 971 | 2000 |
| Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis B Bielekova, M Catalfamo, S Reichert-Scrivner, A Packer, M Cerna, ... Proceedings of the National Academy of Sciences 103 (15), 5941-5946, 2006 | 705 | 2006 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 632 | 2019 |
| Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis R Martin, HF McFarland, JM Boggs Critical reviews in clinical laboratory sciences 32 (2), 121-182, 1995 | 623 | 1995 |
| Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients PA Muraro, DC Douek, A Packer, K Chung, FJ Guenaga, ... The Journal of experimental medicine 201 (5), 805-816, 2005 | 536 | 2005 |
| TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways I Štefanová, B Hemmer, M Vergelli, R Martin, WE Biddison, RN Germain Nature immunology 4 (3), 248-254, 2003 | 534 | 2003 |
| The OSCAR-IB consensus criteria for retinal OCT quality assessment P Tewarie, L Balk, F Costello, A Green, R Martin, S Schippling, A Petzold PloS one 7 (4), e34823, 2012 | 450 | 2012 |
| Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system M Prinz, H Schmidt, A Mildner, KP Knobeloch, UK Hanisch, J Raasch, ... Immunity 28 (5), 675-686, 2008 | 439 | 2008 |
| The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis N Sommer, PA Löschmann, GH Northoff, M Weller, A Steinbrecher, ... Nature medicine 1 (3), 244-248, 1995 | 438 | 1995 |
| Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S Brocke, K Gijbels, M Allegretta, I Ferber, C Piercy, T Blankensteini, ... Nature 379 (6563), 343-346, 1996 | 431 | 1996 |
| Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis HF McFarland, JA Frank, PS Albert, ME Smith, R Martin, JO Harris, ... Annals of neurology 32 (6), 758-766, 1992 | 426 | 1992 |
| Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. R Martin, D Jaraquemada, M Flerlage, J Richert, J Whitaker, EO Long, ... Journal of immunology (Baltimore, Md.: 1950) 145 (2), 540-548, 1990 | 426 | 1990 |
| Development of biomarkers in multiple sclerosis B Bielekova, R Martin Brain 127 (7), 1463-1478, 2004 | 401 | 2004 |
| Exploring the origins of grey matter damage in multiple sclerosis M Calabrese, R Magliozzi, O Ciccarelli, JJG Geurts, R Reynolds, R Martin Nature Reviews Neuroscience 16 (3), 147-158, 2015 | 398 | 2015 |
| Identification of high potency microbial and self ligands for a human autoreactive class II–restricted T cell clone B Hemmer, BT Fleckenstein, M Vergelli, G Jung, H McFarland, R Martin, ... The Journal of experimental medicine 185 (9), 1651-1660, 1997 | 394 | 1997 |
Bruno GranConsultant and Hon. Associate Professor of Neurology, Nottingham University Hospitals NHS Trust在 nuh.nhs.uk 的电子邮件经过验证
